Study in COvid-19 Patients With iveRmectin (CORVETTE-01)
NCT04703205
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
214
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Ivermectin 3 MG
DRUG:
Placebo
Sponsor
Kitasato University